27
Participants
Start Date
July 12, 2017
Primary Completion Date
April 28, 2023
Study Completion Date
May 31, 2023
Allogeneic Derived Cells
patients will have the CAP-1002 solution delivered through a coronary catheter inserted in the right and left coronary arteries using standard techniques in the cardiac catheterization laboratory. A right heart catheter will be used to obtain baseline (pre-infusion) hemodynamics.
Placebo/Control Arm
patients will receive the placebo through a coronary catheter inserted in the right and left coronary arteries using standard techniques in the cardiac catheterization laboratory. A right heart catheter will be used to obtain baseline (pre-infusion) hemodynamics.
Medical University of South Carolina, Charleston
Medical University of South Carolina
OTHER
Cedars-Sinai Medical Center
OTHER